Several studies have suggested that T cell priming in the tumor draining lymph node is required to mount anti-tumor immunity (79, 80) A study showed that tumor-associated cDC1 bearing intact tumor Ag traffic to the draining lymph node to prime naïve CTLs in a CCR7-dependent manner (80). The gene discussed is CCR7; the disease is neoplasm.